Skip to main content

Table 3 COPD-Related Adjusted Multivariate Costs (2008 USD) and Unadjusted Costs Per Month in the Follow-up Period by Cohort

From: Observational study on the impact of initiating tiotropium alone versus tiotropium with fluticasone propionate/salmeterol combination therapy on outcomes and costs in chronic obstructive pulmonary disease

 

TIO

TIO + FSC

P value

 

n = 2481

n = 852

 

Adjusted Costs: mean monthly costs per patient (95% CI)

Total

$721 ($190-$2005)

$721 ($149-$2250)

NS

Pharmacy

$190 ($67-$379)

$223 ($62-$490)

NS

Medical

$543 ($66-$3543)

$490 ($42-$4044)

NS

Unadjusted Costs: mean (SD) monthly costs per patient

Total

$782 ($3496)

$598 ($1579)

0.039

Pharmacy

$194 ($220)

$206 ($195)

0.113

Medical

$588 ($3472)

$392 ($1554)

0.026

  1. NS = nonsignificant